TR200902923T2 - Megestrol maddenin farmasötik olarak kararlı bir süspansiyonu. - Google Patents

Megestrol maddenin farmasötik olarak kararlı bir süspansiyonu.

Info

Publication number
TR200902923T2
TR200902923T2 TR2009/02923T TR200902923T TR200902923T2 TR 200902923 T2 TR200902923 T2 TR 200902923T2 TR 2009/02923 T TR2009/02923 T TR 2009/02923T TR 200902923 T TR200902923 T TR 200902923T TR 200902923 T2 TR200902923 T2 TR 200902923T2
Authority
TR
Turkey
Prior art keywords
megestrol
stable suspension
pharmaceutically stable
agent
suspension
Prior art date
Application number
TR2009/02923T
Other languages
English (en)
Inventor
Wook Kim Sang
Kyoon Yoon Suk
Hong Min Mi
Original Assignee
Lg Life Sciences Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd. filed Critical Lg Life Sciences Ltd.
Publication of TR200902923T2 publication Critical patent/TR200902923T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bu buluş: aktif bileşen olarak bir megestrol madde, ıslatıcı madde olarak bir poloksamer ve bir viskozite kontrol maddesi içeren bir süspansiyon ile ilgilidir.
TR2009/02923T 2006-10-19 2007-10-11 Megestrol maddenin farmasötik olarak kararlı bir süspansiyonu. TR200902923T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060102003A KR20080035374A (ko) 2006-10-19 2006-10-19 약제학적으로 안정한 메게스트롤 물질의 현탁액제

Publications (1)

Publication Number Publication Date
TR200902923T2 true TR200902923T2 (tr) 2009-06-22

Family

ID=39314202

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/02923T TR200902923T2 (tr) 2006-10-19 2007-10-11 Megestrol maddenin farmasötik olarak kararlı bir süspansiyonu.

Country Status (4)

Country Link
KR (1) KR20080035374A (tr)
CN (1) CN101553208B (tr)
TR (1) TR200902923T2 (tr)
WO (1) WO2008048018A1 (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2740492A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
CN105769763A (zh) * 2016-05-25 2016-07-20 西安德天药业股份有限公司 一种醋酸甲地孕酮纳米混悬液及其制备方法和应用
EP3471725A4 (en) * 2016-06-16 2020-01-22 Cutispharma, Inc. COMPOSITION AND METHOD FOR SUSPENDING A PROTON PUMP INHIBITOR
CN109922801B (zh) 2016-09-09 2023-07-18 库蒂斯制药公司 甲硝唑和巴氯芬的混悬剂和稀释剂
US10751333B1 (en) 2019-07-16 2020-08-25 Cutispharma, Inc. Compositions and kits for omeprazole suspension
US11633478B2 (en) 2019-07-16 2023-04-25 Azurity Pharmaceuticals, Inc. Compositions and kits for Omeprazole suspension

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338732A (en) * 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
US6268356B1 (en) * 1998-04-20 2001-07-31 Pharmaceutical Resources, Inc. Flocculated suspension of megestrol acetate
US20020028794A1 (en) * 2000-07-21 2002-03-07 Brubaker Greg Allen Megestrol acetate suspension
US9101540B2 (en) * 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations

Also Published As

Publication number Publication date
KR20080035374A (ko) 2008-04-23
WO2008048018A1 (en) 2008-04-24
CN101553208B (zh) 2012-01-25
CN101553208A (zh) 2009-10-07

Similar Documents

Publication Publication Date Title
NO20083630L (no) Nye pyridinderivater
MY154909A (en) Novel thiophene derivatives
TW200700406A (en) Novel thiophene derivatives
TW200716591A (en) Novel thiophene derivatives
TW200708511A (en) Novel thiophene derivatives
TW200716552A (en) Novel thiophene derivatives
TW200738670A (en) Novel thiophene derivatives
NO20080068L (no) Topisk unguale formuleringer
MX2010004576A (es) Derivados de pirimidina novedosos.
WO2006117217A3 (de) Neue verwendung von spiegelmeren
MY149529A (en) Novel agricultural composition
TR201902125T4 (tr) Si̇stemi̇k olarak etki̇ eden akti̇f ajanlari i̇çeren parazi̇ti̇si̇dal oral veteri̇nerli̇ğe ai̇t bi̇leşi̇mler, bunlarin yöntemleri̇ ve kullanimlari
BRPI0717266A2 (pt) Derivados de oxindol
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
NO20093146L (no) Amino-pyridinderivater som S1P1/EDG1-reseptoragonister
PL2178504T3 (pl) Roztwór oczny na bazie prostagladyn bez środka konserwującego
EA201000089A1 (ru) Применение гомо- и сополимеров для стабилизации составов активных ингредиентов
MY153975A (en) Pyridine derivatives as s1p1/edg1 receptor modulators
EA200702529A1 (ru) Фунгицидная комбинация биологически активных веществ
EA201170703A1 (ru) Производные адамантилбензамида
TW200942524A (en) Novel aminomethyl benzene derivatives
EA201170680A1 (ru) Ингибиторы акт и p70 s6-киназы
TR200902923T2 (tr) Megestrol maddenin farmasötik olarak kararlı bir süspansiyonu.
FR2873585B1 (fr) Nouvelles formulations galeniques de principes actifs
UY28917A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico